Smart wearables and blood markers could spot Parkinson's years before symptoms worsen

NCT ID NCT07679256

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study aims to find better ways to diagnose Parkinson's disease in its earliest stages. Researchers will use wearable devices to track movement and analyze blood samples for specific markers from nerve cells. By combining these digital and biological clues, they hope to create a model that can identify Parkinson's before typical symptoms become severe. The study includes people with early Parkinson's, those with prodromal signs (like sleep disorders), and healthy volunteers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could enable earlier detection of Parkinson's disease, potentially allowing treatment to start sooner and slow progression.
What could go wrong
This is an observational study developing a diagnostic model, not a treatment trial. The model may not prove accurate enough for clinical use, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Neurology, Fujian Institute of Geriatrics, Fujian Medical University Union Hospital

    RECRUITING

    Fuzhou, Fujian, 350000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.